REGENXBIOvsUnitedHealth

RGNX and UNH stock compared: price, dividend, valuation and results, from SEC filings.

RGNX

REGENXBIO Inc.

$7.16

Value $473M

-0.28%
RGNX's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

REGENXBIO (RGNX) has a market value of $473M and UnitedHealth (UNH) $308B. Over the last year, with dividends, RGNX moved -34.5% and UNH +12.9%. Dividend yield: RGNX none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    RGNX$473M

    UNH$308B

    UNH is 652 times RGNX

  • Revenue, 12 months

    RGNX$154M

    UNH$450B

    UNH is 2,922 times RGNX

  • Net income, 12 months

    RGNX-$175M

    UNH$15.9B

  • Operating margin

    RGNX-95.7%

    UNH5.3%

    101.0 points apart

  • ROIC

    RGNX-115.2%

    UNH11.3%

    126.5 points apart

  • P/E

    RGNX–

    UNH19.4

  • Dividend yield

    RGNX0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    RGNX-78.6%

    UNH-15.4%

    63.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

RGNX-78.6%

UNH-15.4%

5010015020222023202420252026
Returns by period
PeriodRGNXWith dividendsUNHWith dividends
1 year since November 19, 2025-34.5%Price -34.5%+12.9%Price +10.0%
3 years since November 20, 2023-64.3%-29.0% a yearPrice -64.3%-32.4%-12.2% a yearPrice -36.5%
5 years since November 19, 2021-78.6%-26.6% a yearPrice -78.6%-15.4%-3.3% a yearPrice -22.8%
10 years since November 21, 2016-66.8%-10.4% a yearPrice -66.8%+166.8%+10.3% a yearPrice +125.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

RGNXREGENXBIOUNHUnitedHealth

Valuation

RGNXUNH
Valuation
Price$7.16$339.85
Market value$473M$308B
Enterprise value (EV)–$354B
P/E–19.4
P/E, 5-year median–25.0
P/B3.23.0
EV/EBIT–14.8
Free cash flow yield–7.4%

Results and growth

RGNXUNH
Results and growth
Revenue, 12 months$154M$450B
Net income, 12 months-$175M$15.9B
Free cash flow, 12 months-$155M$22.8B
Earnings per share, 12 months-$3.21$17.52
Revenue growth, year on year104.5%11.8%
Revenue growth a year, past+2.0%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

RGNXUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin-95.7%5.3%
Net margin-113.9%3.5%
ROIC-115.2%11.3%
ROE-173.5%15.5%

Balance sheet

RGNXUNH
Balance sheet
Cash$251M$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover-4.1×6.2×

Dividends and buybacks

RGNXUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: RGNX or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, REGENXBIO or UnitedHealth?

By market value, UnitedHealth ($308B) is about 651.6 times REGENXBIO ($473M), at today's prices.

How did RGNX and UNH stock do over the last 10 years?

Since November 21, 2016, RGNX's price moved -66.8% and UNH's +125.9%. With dividends: RGNX -66.8% (-10.4% a year), UNH +166.8% (+10.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, RGNX or UNH?

The dividend yield at today's price is none for REGENXBIO and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, REGENXBIO or UnitedHealth?

Over the last twelve months, the net margin was -113.9% for REGENXBIO and 3.5% for UnitedHealth, and the operating margin -95.7% and 5.3%. Revenue was $154M and $450B.

Which is the better investment, REGENXBIO or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.